REGENXBIO's partnership with Nippon Shinyaku provides $110M upfront, ensuring a cash runway for gene therapy programs in MPS ...

Regenxbio will receive $110m upfront from Nippon Shinyaku and is eligible to get up to $700m in development, regulatory, and ...

HOUSTON -- Luke Lehnen accounted for five touchdowns Sunday night and North Central beat Mount Union 41-25 to win its third Division III national championship. The Cardinals (15-0) appeared in ...

Though it may not have been a win Patriots fans wanted — with the No. 1 pick in the 2025 NFL draft hanging in the balance — rookie quarterback Joe Milton III provided a breath of fresh air on ...

Elon Musk has become a political lightning rod in the United Kingdom after he advocated for King Charles III to shutdown Parliament and call for a new election. lon Musk's support for dissolving ...

The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal onasemnogene abeparvovec (OAV101 IT) OAV101 IT ...

The Marshall Emberton III is one of the brands smaller speakers, but it packs solid sound into a very tasty-looking design. From the control knob found on loads of Marshall gear to the impactful ...

By Max Bearak and Ash Wu Berrien Moore III, who for decades spearheaded cutting-edge climate science at several universities and research institutes as well as at NASA, died on Dec. 17 in Norman ...

CHICAGO—The Seahawks placed leading rusher Kenneth Walker III on injured reserve Thursday, the result of an ankle injury he suffered late in last weekend's game. Rookie running back George ...

Newsweek magazine delivered to your door Newsweek Voices: Diverse audio opinions Enjoy ad-free browsing on Newsweek.com Comment on articles Newsweek app updates on-the-go ...

Lymphocyte subset enumeration was performed by flowcytometry. 50µl of whole blood were mixed with anti-CD16 (clone 3G8, BD Pharmingen), -CD45-PerCP (clone 2D1, BD Biosciences), -CD19-PE-Cy7 (clone ...

Established in 1945, 3i is one of the UKs biggest investors in private companies. It says its strategy is to go for early stage growth companies rather than the financial wizardry favoured by ...